Kwang Soo Cheong

Corporate Officer/Principal presso Carey Business School

63 anni

Consumer Services

Health Technology

Profilo

Kwang Soo Cheong is currently an Associate Professor at Carey Business School since 2005.
He previously worked as an Independent Director at Rexahn Pharmaceuticals, Inc. He also served as an Assistant Professor-Economics at the University of Hawai'i at Hilo from 1994 to 2001.
Dr. Cheong holds a doctorate degree from Stanford University and has completed his undergraduate and graduate studies at Seoul National University.

Posizioni attive di Kwang Soo Cheong

Società	Posizione	Inizio
Carey Business School	Corporate Officer/Principal	01/01/2001

Tutte le posizioni attive di Kwang Soo Cheong

Precedenti posizioni note di Kwang Soo Cheong

Società	Posizione	Fine
University of Hawai'i at Hilo University of Hawai'i at Hilo Other Consumer ServicesConsumer Services University of Hawai'i at Hilo engages in the provision of services relating to higher education. It offers bachelor’s degrees, minors, master’s degrees, doctoral degrees, certificate programs, graduate certificate programs, and distance learning. The company was founded in 1947 and is headquartered in Hilo, HI.	Corporate Officer/Principal	01/01/2001
REXAHN PHARMACEUTICALS, INC.	Direttore/Membro del Consiglio	-

Vedi nel dettaglio l'esperienza di Kwang Soo Cheong

Formazione di Kwang Soo Cheong

Seoul National University	Graduate Degree
Stanford University	Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Kwang Soo Cheong

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	1
Rexahn Pharmaceuticals, Inc. Rexahn Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rexahn Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of oncology therapeutics. Its drug candidates include the following: RX-31171 for pancreatic, bladder, colon, and lung cancer; and RX-5902 for metastatic triple negative breast cancer. The company was founded by Chang Ho Ahn on March 19, 2001 and is headquartered in Rockville, MD.	Health Technology